Next-generation gene panel testing in adolescents and adults in a medical neuropsychiatric genetics clinic
- 7 August 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in neurogenetics
- Vol. 22 (4), 313-322
- https://doi.org/10.1007/s10048-021-00664-3
Abstract
Intellectual disability (ID) encompasses a clinically and genetically heterogeneous group of neurodevelopmental disorders that may present with psychiatric illness in up to 40% of cases. Despite the evidence for clinical utility of genetic panels in pediatrics, there are no published studies in adolescents/adults with ID or autism spectrum disorder (ASD). This study was approved by our institutional research ethics board. We retrospectively reviewed the medical charts of all patients evaluated between January 2017 and December 2019 in our adult neuropsychiatric genetics clinic at the McGill University Health Centre (MUHC), who had undergone a comprehensive ID/ASD gene panel. Thirty-four patients aged > 16 years, affected by ID/ASD and/or other neuropsychiatric/behavioral disorders, were identified. Pathogenic or likely pathogenic variants were identified in one-third of our cohort (32%): 8 single-nucleotide variants in 8 genes (CASK, SHANK3, IQSEC2, CHD2, ZBTB20, TREX1, SON, and TUBB2A) and 3 copy number variants (17p13.3, 16p13.12p13.11, and 9p24.3p24.1). The presence of psychiatric/behavioral disorders, regardless of the co-occurrence of ID, and, at a borderline level, the presence of ID alone were associated with positive genetic findings (p = 0.024 and p = 0.054, respectively). Moreover, seizures were associated with positive genetic results (p = 0.024). One-third of individuals presenting with psychiatric illness who met our red flags for Mendelian diseases have pathogenic or likely pathogenic variants which can be identified using a comprehensive ID/ASD gene panel (~ 2500 genes) performed on an exome backbone.Funding Information
- Canada First Research Excellence Fund
- McGill University Health Centre
This publication has 69 references indexed in Scilit:
- Deletion at the SLC1A1 glutamate transporter gene co‐segregates with schizophrenia and bipolar schizoaffective disorder in a 5‐generation familyNeuropsychiatric Genetics, Part B of the American Journal of Medical Genetics (AJMG), 2013
- Treatable inborn errors of metabolism causing intellectual disability: A systematic literature reviewMolecular Genetics and Metabolism, 2012
- Psychiatric Features in Children with Genetic Syndromes: Toward Functional PhenotypesPediatric Clinics of North America, 2011
- Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital AnomaliesAmerican Journal of Human Genetics, 2010
- Copy number variations of chromosome 16p13.1 region associated with schizophreniaMolecular Psychiatry, 2009
- Intellectual disability co-occurring with schizophrenia and other psychiatric illness: population-based studyThe British Journal of Psychiatry, 2008
- Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adultsJournal of Inherited Metabolic Disease, 2007
- Heterozygous Mutations in TREX1 Cause Familial Chilblain Lupus and Dominant Aicardi-Goutières SyndromeAmerican Journal of Human Genetics, 2007
- Deletion of CASK in mice is lethal and impairs synaptic functionProceedings of the National Academy of Sciences of the United States of America, 2007
- Mental ill-health in adults with intellectual disabilities: prevalence and associated factorsThe British Journal of Psychiatry, 2007